trending Market Intelligence /marketintelligence/en/news-insights/trending/jjvipj1hztbdi9jibsulhq2 content esgSubNav
In This List

Theravance Biopharma adds independent director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Theravance Biopharma adds independent director

Theravance Biopharma Inc. appointed Laurie Alsup as an independent director.

Alsup is the COO and chief scientific officer of NDA Group.